Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Sep 17, 2021 6:24pm
130 Views
Post# 33882063

RE:So 6 earnings beats in a row will it be 7?

RE:So 6 earnings beats in a row will it be 7?Wofats ... your question is good but I don't think you're missing anything.

I believe the control at GUD is in the hands of very few.  As I noted ... in 2019, the AGM operator announced 270 investors were present and they accounted for 70% of the voting shares at that time.  I believe that to still be the case because the 2020 and 2021 AGM board voting is almost a mirror image of the 2019 voting.  Therefore, nothing is really changing with the biggest investors - it's the float that keeps getting bounced around like a hot potatoe.

Some get in, expected things to happen over the next few quarters, nothing happens, and so they exit vowing never to come back.  This goes on for years.

GUD is a relatively unknown company and the jump in share price will sort of happen like you'd expect - it will be a herd mentality ... kind of revelation.

Analysts will start to get excited about operational growth consistancy - the company will show steady ongoing growth (operationally) mixed in with some cool acquisitions to drive shareholder excitement.  We just don't know when that "real" excitment takes place.

Like you noted - that period for Paladin ... specifically the years 2002-2003 is where I entered and I waited and waited.  No one talked about it on social media or on BNN.  Sort of like today.  The market is cold on them because the path forward isn't obvious ... and ... South America is a little scary for most investors.  One day - the fence sitters start jumping off and picking up some shares - people start talking about the expected growth and institutional investors fire the starting gun to start adding it as a staple to certain product offerings.

We're just not there - we are still being held by the same 70% that started with Goodman and we've got a whole lot of transients making their way in ... and making their way out.

Once the demand outweighs the supply ... you'll know ... we'll all know.  Unfortunately ... we don't know when that happens.  Didn't know it the first time and we'll keep trying to guess it this time.

As such ... I made the decision in 2014 that this time around I will buy in and I would accumulate until we get to that point.  That way, I will have amassed a decent number of shares to springboard from.

Not sure if you can draw any real differences to Paladin by looking at the old graph - I think it's best to view it as a period of growth and moving sideways (now) - followed by the initial excitement as GUD proves the operational growth strategy $12-15-20 range - followed by some steady climb as we show steady growth.  We'll only see jumps if we see big growth drivers added - but - with a ROW built ... I see the potential for big growth drivers without doing a whole lot of work.

We'll see ... but it's all about supply/demand (IMO).

Hope that helps.





wofats wrote:

I still must be missing something 

The last quarter earinings consensuss was for -.07  They earned .23,a .30 beat.
This quarter earning  consensus is for .02.  Last year they earned .14.  I expect 14+ for this quarter
For the full year earnings for 2020 were 31.76 million 
For the second quarter 2021 earnings were 29 million 
2019 EPS .10.    2020 EPS .32.  2021 EPS ? What this number is will make a difference 
Almost 50% of all the stock trades are done on other exchanges ( not the TSX )
It looks as though the growth investors are moving out and the value investers are moving in.

Paladin keeps being brought up.
From 1998 to 2008 the stock price bounced around like a rubber ball.Then they posted earning that made the market and the advisors take notice . Keep in mind Paladin had 21 million shares so any bounce was noticeable . 
 

WHAT AM I MISSING?

 



<< Previous
Bullboard Posts
Next >>